Due to the rise in neurodegenerative illnesses, the disease treatment sector is anticipated to dominate the global Memory Enhancement Drugs Market over the forecast period. The World Health Organisation (WHO), for example, estimates that Parkinson's Disease (PD) caused 330,000 global deaths in 2020, an increase of over 99% since 2001, and 5.7 million life years adjusted for disability, an increase of 80% since 2001.

Due to rising patient traffic in the market for the Memory Enhancement Drugs Market, retail pharmacies are anticipated to have a leading position in the worldwide memory enhancement drugs market during the course of the forecast period. Increased government initiatives for memory-improving drug development are among the key market trends that are anticipated to fuel the market's expansion over the forecast period.